{"id":14150,"date":"2016-12-01T17:40:41","date_gmt":"2016-12-01T17:40:41","guid":{"rendered":"https:\/\/bioengineer.org\/study-examines-association-of-asbestos-exposure-mesothelioma-in-eastern-china\/"},"modified":"2016-12-01T17:40:41","modified_gmt":"2016-12-01T17:40:41","slug":"study-examines-association-of-asbestos-exposure-mesothelioma-in-eastern-china","status":"publish","type":"post","link":"https:\/\/bioengineer.org\/study-examines-association-of-asbestos-exposure-mesothelioma-in-eastern-china\/","title":{"rendered":"Study examines association of asbestos exposure, mesothelioma in Eastern China"},"content":{"rendered":"

A new research letter published online by JAMA Oncology<\/em> looks at asbestos exposure and malignant mesothelioma in Eastern China.<\/p>\n

The study examined tumors diagnosed as malignant mesothelioma from 2002 through 2015 at two Chinese hospitals – one in Hangzhou, China, where there is no asbestos industry and one in Yuyao, China, located in the Chinese textile asbestos industrial area, where most patients are exposed to asbestos.<\/p>\n

The authors reviewed 92 malignant mesotheliomas and confirmed the diagnosis in 28 patients from the hospital in Hangzhou and in 24 patients from Yuyao. The male-to-female ratio was 1 to 4 compared to 4 to 1 in the U.S. Also, 20 of the 52 malignant mesotheliomas occurred in asbestos-exposed individuals at the Hangzhou location and 18 of 24 at Yuyao. <\/p>\n

###<\/p>\n

For more details and the study findings, please visit the For The Media website.<\/p>\n

(JAMA Oncol<\/em>. Published online December 1, 2016. doi:10.1001\/jamaoncol.2016.5487; available pre-embargo at the For The Media website.)<\/p>\n

Editor's Note: The article contains conflict of interest and funding\/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.<\/p>\n

Media Contact<\/strong><\/p>\n

Nana Ohkawa
nohkawa@cc.hawaii.edu
@JAMA_current <\/p>\n

http:\/\/www.jamamedia.org <\/p>\n

############<\/p>\n\n

Story Source: <\/b>Materials<\/a> provided by Scienmag<\/span><\/strong><\/p>\n\n","protected":false},"excerpt":{"rendered":"

A new research letter published online by JAMA Oncology looks at asbestos exposure and malignant mesothelioma in Eastern China.
\n \tThe study examined tumors diagnosed as malignant mesothelioma from 200..<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"footnotes":""},"categories":[185],"tags":[],"class_list":["post-14150","post","type-post","status-publish","format-standard","hentry","category-science-news"],"_links":{"self":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/14150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/comments?post=14150"}],"version-history":[{"count":0,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/14150\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/media?parent=14150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/categories?post=14150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/tags?post=14150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} BIOENGINEER.ORG

Saturday, December 21, 2024
Social icon element need JNews Essential plugin to be activated.
No Result
View All Result
No Result
View All Result
No Result
View All Result
Page 1 of 7687 1 2 … 7,687
No Result
View All Result

Bioengineer.org © Copyright 2023 All Rights Reserved.